Obesity associated with T2DM further amplifies this process by increasing the production of proinflammatory mediators such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), while reducing adiponectin levels, a hormone with anti-inflammatory and insulin-sensitizing properties. Here, TNF is linked to obesity disorder.